Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Pharmacotherapy in obstructive sleep apnoea: a clinical guide
Sleep & breathing = Schlaf & Atmung, 2026;30(4)
Role of Oral Glucagon-Like Peptide-1 Receptor Agonists in Weight Management for Individuals With Overweight or Obesity Without Diabetes: A Network Meta-Analysis of Randomized Controlled Trials
Obesity science & practice, 2026;12(4):e70181
Diagnostic and Management Pitfalls of SGLT2 Inhibitor-Associated Ketoacidosis in the ICU: Lessons Following Cardiac Surgery and GLP-1 Agonist Interaction
Case reports in critical care, 2026;2026:4896065
Integrating GLP-1 Receptor Agonists Into Dermatology Practice: Safety and Monitoring Strategies
Clinics in dermatology, 2026
Incretin-Based Therapies in Obesity-Related Obstructive Sleep Apnea: A Narrative Review of Evidence Tiers and Mechanistic Plausibility
Nature and science of sleep, 2026;18:611573
Patient Experiences and Safety Concerns Regarding GLP-1 Receptor Agonists for Obesity: A Cross-Sectional Survey in Jeddah, Saudi Arabia
Saudi medical journal, 2026;47(9):1516-1523
Venous Congestion in Metabolic Heart Disease: Potential Indirect Role of Dual Incretin Agonists
Cardiovascular & hematological disorders drug targets, 2026
Oral vs. Subcutaneous Semaglutide for Obesity Treatment: A Systematic Review of Efficacy, Safety, and Patient-Oriented Outcomes
Pharmaceuticals (Basel, Switzerland), 2026;19(8)
Effects of Oral Semaglutide on Dietary Intake and Body Composition in Japanese People With Type 2 Diabetes: A Prospective Observational Study in Clinical Practice
Endocrinology, diabetes & metabolism;9(5):e70295
Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease
Journal of the American College of Cardiology;87(11):1369-1373
Improvement of Rosacea With Tirzepatide: A Case Report
Journal of drugs in dermatology : JDD;25(8):749-750
Weight Loss-Dependent Changes in Body Composition and Bone Health in People With Obesity and Type 1 Diabetes Treated With Liraglutide, Semaglutide, or Tirzepatide
Diabetes/metabolism research and reviews;42(6):e70213
Impact of semaglutide introduction on the use of triptans: an interrupted-time series
The journal of headache and pain, 2026;27(1)
Attitudes of Swedish primary care physicians toward GLP-1 receptor agonists for overweight and obesity: a cross-sectional survey
BMC primary care, 2026;27(1)
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1-3 Trials
Diabetes, obesity & metabolism, 2026
Tirzepatide and cardiovascular outcomes
BMJ (Clinical research ed.), 2026;394:e100366
Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study
BMJ (Clinical research ed.), 2026;394:e100011
The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity
Pharmacological research, 2026;:108365
Cup-to-disc ratio in GLP-1 RA Associated Non-Arteritic Anterior Ischemic Optic Neuropathy
Ophthalmology, 2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: A phase 3, randomized, active-controlled, multicenter, non-inferiority trial (WIN-IND study)
Metabolism open, 2026;31:100489